Market Overview:
The global direct-to-consumer disease risk and health test market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing awareness about various diseases and their risk factors, rising incidences of lifestyle diseases, and growing demand for early diagnosis and treatment. In addition, technological advancements in the field of diagnostics are also contributing to the growth of this market. Based on type, the global direct-to-consumer disease risk and health test market is segmented into celiac disease, Parkinson’s disease, Alzheimer’s disease, other diseases, and miscellaneous tests. The celiac disease segment is expected to account for the largest share of this market in 2018 owing to increasing awareness about this disorder among people across the globe. Based on application, this market is divided into online applications and offline applications.
Product Definition:
Direct-to-consumer disease risk and health tests offer people the opportunity to learn about their genetic risk for developing certain diseases. The tests can also help people determine if they carry specific gene variants that could increase their risk for developing a particular condition. Some direct-to-consumer disease risk and health tests are also marketed as cancer screening tests even though they have not been approved by the U.S. Food and Drug Administration (FDA) as such.
Celiac Disease:
Celiac disease (CD) is a permanent genetic mutation affecting the human immune system, leading to abnormal function of the small intestine. The disease has an estimated prevalence of 1 in 100 people worldwide and a higher incidence in North America and Western Europe.
Parkinson Disease:
PD is a degenerative disorder of the central nervous system that affects the body's motor and glandular systems. The disease may occur with or without symptoms. Onset usually occurs in middle-aged people, but it can appear at any age after a period of 20 - 50 years.
The most common symptom associated with PD is walking problems; stiffness, slowness.
Application Insights:
The DTC disease risk and health test market is categorized into two applications, namely online and offline. The online segment dominated the global market in 2017 owing to the growing number of direct-to-consumer (DTC) genetic tests available for various diseases such as Parkinson¢â‚¬â„¢s disease, cystic fibrosis, hemochromatosis, and others.
Offline segment is expected to grow at a lucrative rate over the forecast period due to increasing adoption of these tests by physicians in their offices or clinics along with an increase in awareness regarding new diagnostic technologies among patients suffering from chronic conditions. For instance, according to a study published by Statista in 2018 ¢â‚¬Å“ nearly 60% of Americans aged 65 years or above have had a blood test for heart problems and 40% have had cholesterol tested alone without receiving any information about it in their medical records.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of players, high adoption rate for new technologies, and favorable reimbursement policies are some factors driving the regional market. Moreover, growing awareness about early diagnosis is expected to fuel growth over the forecast period. Asia Pacific is estimated to be fastest-growing region during the forecast period owing to increasing internet penetration and rising disposable income levels in developing economies such as India and China.
The introduction of direct-to-consumer (DTC) tests for disease risk assessment has been met with strong resistance from various quarters across developed countries including U.S., UK, Germany etc.
Growth Factors:
- Increasing awareness of the importance of health and preventive care.
- Growing demand for personalized health care services and products.
- Advances in technology that make it easier and more affordable to conduct health tests at home.
- The increasing popularity of healthy lifestyle trends, such as veganism and organic living, that has led to a heightened interest in personal health data tracking and analysis.
Scope Of The Report
Report Attributes
Report Details
Report Title
Direct-to-consumer Disease Risk and Health Test Market Research Report
By Type
Celiac Disease, Parkinson Disease, Alzheimer Disease, Other
By Application
Online, Offline
By Companies
23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Direct-to-consumer Disease Risk and Health Test Market Report Segments:
The global Direct-to-consumer Disease Risk and Health Test market is segmented on the basis of:
Types
Celiac Disease, Parkinson Disease, Alzheimer Disease, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online, Offline
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 23andMe
- MyHeritage
- LabCorp
- Myriad Genetics
- Ancestry.com
- Quest Diagnostics
- Gene By Gene
- DNA Diagnostics Center
- Invitae
- IntelliGenetics
- Ambry Genetics
- Living DNA
- EasyDNA
- Pathway Genomics
- Centrillion Technology
- Xcode
- Color Genomics
- Anglia DNA Services
- African Ancestry
- Canadian DNA Services
- DNA Family Check
- Alpha Biolaboratories
- Test Me DNA
- 23 Mofang
- Genetic Health
- DNA Services of America
- Shuwen Health Sciences
- Mapmygenome
- Full Genomes
Highlights of The Direct-to-consumer Disease Risk and Health Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Celiac Disease
- Parkinson Disease
- Alzheimer Disease
- Other
- By Application:
- Online
- Offline
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Direct-to-consumer Disease Risk and Health Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Direct-to-consumer disease risk and health test is a term used to describe a type of marketing where companies sell products directly to consumers. These products may be supplements, foods, or other health-related items.
Some of the key players operating in the direct-to-consumer disease risk and health test market are 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes.
The direct-to-consumer disease risk and health test market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Direct-to-consumer Disease Risk and Health Test Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Direct-to-consumer Disease Risk and Health Test Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Direct-to-consumer Disease Risk and Health Test Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Direct-to-consumer Disease Risk and Health Test Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Direct-to-consumer Disease Risk and Health Test Market Size & Forecast, 2018-2028
4.5.1 Direct-to-consumer Disease Risk and Health Test Market Size and Y-o-Y Growth
4.5.2 Direct-to-consumer Disease Risk and Health Test Market Absolute $ Opportunity
Chapter 5 Global Direct-to-consumer Disease Risk and Health Test Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Type
5.2.1 Celiac Disease
5.2.2 Parkinson Disease
5.2.3 Alzheimer Disease
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Direct-to-consumer Disease Risk and Health Test Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Applications
6.2.1 Online
6.2.2 Offline
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Direct-to-consumer Disease Risk and Health Test Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Direct-to-consumer Disease Risk and Health Test Analysis and Forecast
9.1 Introduction
9.2 North America Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Type
9.6.1 Celiac Disease
9.6.2 Parkinson Disease
9.6.3 Alzheimer Disease
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Applications
9.10.1 Online
9.10.2 Offline
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Direct-to-consumer Disease Risk and Health Test Analysis and Forecast
10.1 Introduction
10.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Type
10.6.1 Celiac Disease
10.6.2 Parkinson Disease
10.6.3 Alzheimer Disease
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Applications
10.10.1 Online
10.10.2 Offline
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Direct-to-consumer Disease Risk and Health Test Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Type
11.6.1 Celiac Disease
11.6.2 Parkinson Disease
11.6.3 Alzheimer Disease
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Applications
11.10.1 Online
11.10.2 Offline
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Direct-to-consumer Disease Risk and Health Test Analysis and Forecast
12.1 Introduction
12.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Type
12.6.1 Celiac Disease
12.6.2 Parkinson Disease
12.6.3 Alzheimer Disease
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Applications
12.10.1 Online
12.10.2 Offline
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Direct-to-consumer Disease Risk and Health Test Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Type
13.6.1 Celiac Disease
13.6.2 Parkinson Disease
13.6.3 Alzheimer Disease
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Applications
13.10.1 Online
13.10.2 Offline
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Direct-to-consumer Disease Risk and Health Test Market: Competitive Dashboard
14.2 Global Direct-to-consumer Disease Risk and Health Test Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 23andMe
14.3.2 MyHeritage
14.3.3 LabCorp
14.3.4 Myriad Genetics
14.3.5 Ancestry.com
14.3.6 Quest Diagnostics
14.3.7 Gene By Gene
14.3.8 DNA Diagnostics Center
14.3.9 Invitae
14.3.10 IntelliGenetics
14.3.11 Ambry Genetics
14.3.12 Living DNA
14.3.13 EasyDNA
14.3.14 Pathway Genomics
14.3.15 Centrillion Technology
14.3.16 Xcode
14.3.17 Color Genomics
14.3.18 Anglia DNA Services
14.3.19 African Ancestry
14.3.20 Canadian DNA Services
14.3.21 DNA Family Check
14.3.22 Alpha Biolaboratories
14.3.23 Test Me DNA
14.3.24 23 Mofang
14.3.25 Genetic Health
14.3.26 DNA Services of America
14.3.27 Shuwen Health Sciences
14.3.28 Mapmygenome
14.3.29 Full Genomes
